Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar 25;17(3):e81197.
doi: 10.7759/cureus.81197. eCollection 2025 Mar.

Veno-Arterial Extracorporeal Membrane Oxygenation for Treating Refractory Shock in Severe Metformin-Associated Lactic Acidosis: A Case Report

Affiliations
Case Reports

Veno-Arterial Extracorporeal Membrane Oxygenation for Treating Refractory Shock in Severe Metformin-Associated Lactic Acidosis: A Case Report

Kisei Sai et al. Cureus. .

Abstract

Metformin-associated lactic acidosis (MALA) is a rare but life-threatening complication with mortality rates exceeding 10-30%. While renal replacement therapy (RRT) remains the cornerstone of treatment, mechanical circulatory support may be necessary in cases complicated by severe cardiovascular dysfunction. We report a case of severe MALA with unprecedented metabolic derangement successfully treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and continuous renal replacement therapy (CRRT). A 39-year-old male with type 2 diabetes mellitus presented with altered mental status following influenza A infection. Initial assessment revealed severe metabolic acidosis (pH 6.355) with markedly elevated lactate (52.7 mmol/L), acute kidney injury, and cardiovascular collapse. Echocardiography demonstrated severe left ventricular dysfunction with an ejection fraction below 20%. Despite initial resuscitation efforts, including high-dose vasopressors, the patient developed cardiac arrest with pulseless electrical activity, requiring cardiopulmonary resuscitation. After the return of spontaneous circulation, VA-ECMO was initiated for refractory shock unresponsive to high-dose vasopressors. MALA was diagnosed based on the clinical presentation and medication history, although metformin levels could not be measured due to assay unavailability. Under combined VA-ECMO and CRRT support, the patient's metabolic parameters improved steadily, with a gradual decrease in lactate levels and an improvement in pH. Left ventricular function recovered significantly, allowing VA-ECMO discontinuation after 26 hours. The patient was successfully weaned from mechanical ventilation with subsequent rehabilitation, achieving discharge with intact cognitive function and no neurological sequelae. By this time, both cardiac and renal functions had normalized. This case demonstrates the successful use of mechanical circulatory support in extreme metabolic derangement and illustrates how viral illnesses can precipitate severe MALA through acute kidney injury. The successful outcome suggests that early recognition and aggressive intervention with combined VA-ECMO and CRRT might be beneficial in selected patients with MALA-induced cardiovascular collapse. This case also highlights the importance of considering MALA in unexplained severe lactic acidosis, particularly in diabetic patients during acute illness.

Keywords: continuous renal replacement therapy (crrt); metformin-associated lactic acidosis; refractory shock; severe acidemia; veno-arterial extracorporeal membrane oxygenation (va ecmo).

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Temporal variation in the lactate concentration and pH after admission

Similar articles

References

    1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Inzucchi SE, Bergenstal RM, Buse JB, et al. Diabetes Care. 2012;35:1364–1379. - PMC - PubMed
    1. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. JAMA. 2014;312:2668–2675. - PMC - PubMed
    1. Incidence of lactic acidosis in metformin users. Stang M, Wysowski DK, Butler-Jones D. Diabetes Care. 1999;22:925–927. - PubMed
    1. Clinical presentations and prognosis of metformin-associated lactic acidosis patients in the intensive care unit: a 20-year survey. Yang CC, Weng SF, Tseng KL, Ho CH. Medicine (Baltimore) 2022;101:0. - PMC - PubMed
    1. Metformin-associated lactic acidosis and factors associated with 30-day mortality. Thammavaranucupt K, Phonyangnok B, Parapiboon W, et al. PLoS One. 2022;17:0. - PMC - PubMed

Publication types

LinkOut - more resources